bharat biotech phase 3 trials

Bharat Biotech’s Covaxin 3rd phase clinical trials show 77.8% all round efficacy price vaccine 65.2% successful against Delta variant

Health July 3, 2021

In a substantial development, indigenously created Bharat Biotech’s Coronavirus vaccine Covaxin has been located to be 77.8 % successful against…